menopause; breast cancer; estradiol; testosterone
-
FDA Guidance on Development Pathway for Women’s T-Therapy and New Evidence of a Reduced Risk of Breast Cancer Cell Proliferation for AVA-291(d3-T)
* “d3-T is a novel, structurally identical form of testosterone where select hydrogen molecules have been substituted with deuterium. This small change creates a significant breakthrough.” * AVA-291 is a “next-generation testosterone designed to retain [testosterone]’s androgen activity while...- madman
- Thread
- menopause; breast cancer; estradiol; testosterone
- Replies: 2
- Forum: HRT in Women
Sponsors
